Specialist QC IPC Support

Xellia Pharmaceuticals

  • København
  • Permanent
  • Fuldtid
  • 1 måned siden
Specialist QC IPC Support
QualityResponsibilities:
  • Coordination and reporting of validation/transfer of instrumental (HPLC, UPLC, GC, IR, UV, etc.) and classical analytical methods
  • Checking, trending and statistical evaluation of analytical results related to validation processes
  • Optimization and development of instrumental and classical analytical methods
  • Close co-operation with colleagues at other Xellia sites regarding validation and development tasks
  • Participation in Change Control and CAPA processes
  • Participation in pharmacopeial review
  • Active involvement in the operation and development of laboratory-supporting systems
  • Preparation and review of quality management documents
  • Use of LIMS and other pharmaceutical, analytical and quality assurance software
Requirements:
  • Bachelor of Science degree in chemistry or related sciences
  • Minimum 1 year experience in instrumental and classical analytics (routine quality control or research & development)
  • Professional English knowledge (oral and written)
  • GMP knowledge, reliability
  • Good communication skills
  • System thinking and problem-solving skills
  • Ability to work independently and as part of a team
What We Offer:
  • Competitive compensation and benefit package
  • „Nordic-style” culture - dynamic teamwork, good working atmosphere, flexibility, maintaining work-life balance
  • Opportunity to learn and develop
  • Good team spirit and friendly colleagues
  • Stable international company background
  • Multinational working environment
  • Medical Screenings
  • Sport Allowances
  • Home office
Xellia Pharmaceuticals is a specialty pharmaceutical company and a global leader in providing anti-infective treatments and other critical care therapies for serious and often life-threatening conditions. Xellia has an extensive heritage in developing, manufacturing, and commercializing anti-infective products.Headquartered in Copenhagen, Denmark, and owned by Novo Holdings A/S, Xellia Pharmaceuticals has more than 1400 employees globally, including state-of-the-art manufacturing sites in China, Denmark, and Hungary. Our strong market position is built on more than 120 years of pharmaceutical industry experience.Further information about Xellia can be found at:
Connect with us on

Xellia Pharmaceuticals